Ajanta Pharma USA Inc: Fenofibrate Capsules, Usp 200 Mg
Fenofibrate Capsules Recall Summary Ajanta Pharma USA Inc is recalling Fenofibrate Capsules 200 mg (NDC 27241-120-04) distributed nationwide due to manufacturing practice deviations. This prescription medication was distributed across all U.S. states and Washington, D.C. The recall is classified as Class II, indicating a potential health risk.
- Recalling firm
- Ajanta Pharma USA Inc
- Product
- Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.
- Reason
- CGMP Deviations
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-05-28
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- U.S. Nationwide
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/214e9ecd-a135-4522-8e0a-6f1ae5ad13a8